Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 18 min ago

GP surgery closures hit ‘all-time-high’ last year

03/06/2019
The closures are directly affecting smaller practices, with nine out of 10 practices that closed serving fewer than 5,000 patients.

NICE recommendation for MSD’s Prevymis after re-evaluation

03/06/2019
Prevymis is a member of a new class of drugs called non-nucleoside CMV inhibitors.

Novartis hits targets in late-stage QMF149 asthma trial

31/05/2019
The once-daily, fixed-dose treatment demonstrated significant improvements in lung function and asthma control.

BMJ study shows correlation between processed foods and CV disease

31/05/2019
Cardiovascular disease is the main cause of death worldwide, representing one third of all deaths globally.

NICE issues guidance revision for depression

31/05/2019
The governing body has been urged to undergo a “full and proper revision” of its 2009 guideline on adult depression.

Milestone achieved in J&J’s investigational HIV study

31/05/2019
Johnson & Johnson has announced full enrolment in its proof-of-concept efficacy study of Imbokodo.

NHS to launch new online type II diabetes support

30/05/2019
The new online portal will offer people with type II diabetes evidence-based information and support.

Record number of cancer drugs launched in 2018, says report

30/05/2019
The IQVIA report also explores health system barriers hindering the realisation of the benefits of those therapies and drug candidates.

FDA breakthrough therapy designation granted for Bayer’s Aliqopa

30/05/2019
The decision was primarily based on follow-up data from the pivotal Phase II study CHRONOS-1.

Univar’s Cufence leads latest CHMP decisions

30/05/2019
The committee recommended four treatments including two generic medicines.

Sosei get $2.5m for QVM149 MAA

29/05/2019
The company recently announced positive data from two Phase II clinical studies, in which QVM149 was shown to be superior to the comparators.

Positive late stage rheumatoid arthritis trial results for Abbvie

29/05/2019
Upadacitinib was found to have achieved both primary endpoints with significantly higher rates of ACR20 response and low disease activity at week 14.

Inpatients seen within target time falls to 68% in Scotland

29/05/2019
Professor Derek Bell of the Royal College of Physicians of Edinburgh spoke out against the worsening figures.

EMA gives trastuzumab biosimilar Marketing Authorisation Application

29/05/2019
The drug is Prestige’s lead development candidate biosimilar to Roche’s Herceptin.

FDA approval for Novartis’ Piqray

28/05/2019
The FDA approval is based on a Phase III trial, SOLAR-1, in which the combination nearly doubled median progression free survival.

Theresa May failed to tackle “country’s biggest injustices”, says NHS

28/05/2019
Back in 2018 she announced that the NHS was to receive an extra £20 billion a year by 2023.

Santhera submits MAA to EMA for Puldysa

28/05/2019
The company is seeking conditional marketing authorisation (CMA) for patients with DMD who are not using glucocorticoids.

New molecular diagnostics business launched in Manchester

28/05/2019
The aim of APIS Assay Technologies is to help to realise the clinical and commercial potential of genomic medicine in diagnostic tests and personalisation of treatment.

Zolgensma wins FDA green light in child SMA

28/05/2019
The $2.1 milllion per treatment price tag has garnered substantial criticism.

Pages

X